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Figure 4. Ofirmev® Orders Since 4/1/17, by month
Figure 2. IV Pain Med Order-Set Use Over Time
Figure 3. Medications Ordered via IV Pain 
Medication Order-Set
Figure 6. Location of Providers Ordering Ofirmev® 
using IV Pain Med Order-Set
In total, there were 14,390 total Ofirmev® orders placed 
since 4/1/17. This included 7,800 in the last year alone 
(2019) compared to 4,207 in 2018 (Fig. 4).
The most common units in which Ofirmev® was ordered 
were the operating rooms, ICU, and floor – specifically 
surgical units (Fig. 5).
There were 86 Ofirmev® orders placed via order-set.
In total, 20 such orders were placed via the IV pain 
med order-set (Fig. 6).
Figure 5. Location of Providers Ordering Ofirmev® 
since 4/1/17 (Overall)
GROSS Committee
The Getting Rid of Stupid Stuff (GROSS) Committee is 
a resident-led group of general surgical residents that was 
created to optimize EPIC-related workflows. Our goal is to 
identify inefficient processes and to work with EPIC 
implementation groups to enact changes to standardize work 
processes, reduce provider fatigue, and improve patient care. 
Here, we describe a process-improvement project geared 
toward streamlining the ordering of pain medications and 
reducing unnecessary medication use.
Background
In the postoperative setting, patients routinely need to 
transfer from a nil per os (NPO) status to other diets as their 
care is advanced, or from diets to NPO if they are not 
tolerating a diet. We sought to streamline the changing of 
pain medication orders back and forth from IV to PO.
Additionally, intravenous (IV) acetaminophen (Ofirmev®) is 
a non-opiate analgesic that is both highly efficacious in pain 
relief and very expensive. Many hospital systems have sought 
to curb its use to situations in which patients are NPO. 
Through a partnership with the P&T Committee at Jefferson, 
we initiated a pilot program to encourage and identify 
appropriate and judicious clinical use of IV acetaminophen.
The aims of this project were to:
1) Streamline the ordering of IV and PO pain meds
2) Encourage the appropriate ordering of Ofirmev®
Figure 1. IP J SUR NPO Pain Medications Order-Set
Results: Order-Set Use
The IV pain medication order-set was introduced in August 
2019. Since then, it has been used 77 times (Fig. 2). 
Results: Ofirmev® Use
Results: Ofirmev® Use (Cont.)
Conclusions & Future Directions
Creation of a dedicated order-set for ordering pain 
medications can simplify workflow for residents, but 
widespread adoption remains a challenge. The use of 
Ofirmev® increased until late 2019 and then decreased. 
Further evaluation into reasons for this decline may show 
important patterns that could aide in the development of cost-
and clinically-effective pain treatment algorithms.
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**All medications IV unless otherwise indicated
